Abstract
From 1977 to 1988, 84 resections of pulmonary metastases were performed, and 55 patients were followed for more than two years. Their cumulative survival rates were 76. 4% at one year, 39. 6% at three years and 26. 4% at five years, with a median survival time of 35 months. The prognosis was somewhat influenced by tumor doubling time (TDT), disease free interval (DFI) and the number of metastases. A TDT of more than 70 days and a DFI of more than 12 months were favorable prognostic factors. Some metastatic tumors grow rapidly after a long dormant period. Patients with such tumors have a chance to be cured by tumor resection when there are few metastases in the lungs and no evidence of metastasis in other organs Multimodal treatment, including repeated thoracotomies, contributes to prolongation of survival.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: The Journal of the Japanese Association for Chest Surgery
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
